# Analysis: STE_2026_Q1.txt

*Model: gpt-3.5-turbo*

---

### 1. Quarter & Company Context
- **Company:** Starris PLC (Ticker: STPLC)
- **Fiscal Quarter/Year:** First Quarter 2026
- **Key Context:** Management highlighted a 9% total revenue growth, with 8% constant currency organic revenue growth driven by volume and price increases. Gross margin improved by 20 basis points to 45.3%.

### 2. Headline Financial Results
- **Revenue:** 9% growth
- **EPS:** Adjusted EPS from continuing operations increased by 15% to $2.34
- **Margins:** Gross margin increased by 20 basis points to 45.3%
- **Guidance:** Revised revenue growth to approximately -9%, maintaining constant currency organic revenue growth at 6-7%

### 3. Management Commentary
- **Strategic Initiatives:** Highlighted strong performance across healthcare, AST, and Life Sciences segments, with positive growth in services, consumables, and capital equipment.
- **Risks:** Mentioned tariff impacts on metals and increased healthcare benefit costs affecting earnings.

### 4. Q&A Highlights
- **Analyst Questions:** Focused on tariff impacts, AST segment performance, and regulatory developments.
- **Management Response:** Confident in the company's position, emphasizing strong order intake and backlog.

### 5. Market/Investor Sentiment Signals
- **Forward-Looking Commentary:** Maintained outlook for fiscal 2026, with increased free cash flow guidance by $50 million to $820 million.
- **Surprises:** No significant surprises reported, with a balanced outlook on earnings and margins.

### 6. Takeaways
- **Positive Takeaways:**
  - Strong revenue growth and margin improvement.
  - Confident outlook for free cash flow and continued dividend growth.
- **Negative Takeaways:**
  - Increased tariff impacts and healthcare benefit costs affecting earnings.
  - Regulatory uncertainties and competitive pressures in the market.
- **Uncertainties:**
  - Impact of ongoing regulatory changes on the competitive landscape.
  - Potential effects of healthcare policy shifts on hospital volumes.

### 7. Other Notable Information
- **CFO Transition:** Announcement of CFO transition to Karen, highlighting a smooth transition plan and continued financial leadership.
- **Regulatory Developments:** Discussion on compliance with Nishap regulations and potential impacts on competitive landscape and positioning in EO sterilization market.
- **Market Trends:** Observations on ASC build-out in the US and potential implications for the company's capital business in healthcare.

This structured summary provides a comprehensive overview of Starris PLC's First Quarter 2026 earnings call, highlighting key financial results, management commentary, market sentiment signals, and notable information discussed during the call.